Genocea Biosciences, Inc. filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the District of Massachusetts on July 5, 2022. The debtor listed its assets as $129.94 million and liabilities in the range of $1 million to $10 million. The debtor is represented by Andrew G. Lizotte of Murphy & King, P.C. and Ropes & Gray LLP as its legal counsel.

The debtor also hired Rock Creek Capital Advisors, LLC as financial advisor and OMNI Management Group, LLC as noticing agent.